person
Arnaud P.
- Country
- France
- Department
- Hematology and oncology pediatric
Research Overview
assignment
19
Clinical Trials ·
- Phase 1b Study of the Safety and Pharmacokinetics of Pivekimab Sunirine in Pediatric Patients with Relapsed or Refractory CD123-Positive Acute Myeloid Leukemia
- Randomized Phase 3 Trial of Venetoclax Added to Fludarabine, High‑Dose Cytarabine, and Gemtuzumab Ozogamicin in Children with Relapsed Acute Myeloid Leukemia
- Phase 3 Study of Imatinib with Cytotoxic Chemotherapy in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
location_city
8
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
188
Sites with multiple studies
Has run more than one trial at 188 of 315 partner sites.
Specializations
Acute Leukemia Research
The investigator specializes in treating various forms of acute leukemia, with particular emphasis on pediatric blood cancers. Their work encompasses both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
- FLT3-mutated AML treatment approaches
- Philadelphia chromosome-positive ALL therapy
- Relapsed/refractory leukemia interventions
Solid Tumor Studies
The investigator conducts research in pediatric solid tumors, with significant focus on high-risk neuroblastoma and other advanced malignancies.
- Novel combination therapies
- Targeted treatment approaches
- Immunotherapy applications
Precision Medicine Applications
The investigator employs molecular targeting strategies and personalized treatment approaches for pediatric cancers.
- Molecular anomaly-based therapies
- Targeted kinase inhibitors
- Biomarker-driven treatment selection
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.